2009 Media Kit
Cannabis Use Linked With Increased Risk of Major Adverse Cardiovascular Events
Investigators of a study used a systematic review and meta-analysis to evaluate the risk of major adverse cardiac events related to cannabis by using real-world data.
The Potential Impact Pharmaceutical Tariffs May Have on Pharmacies
Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Drug Topics to help us understand how pharmaceutical tariffs could potentially impact the pharmacy industry.
FDA Approves Nitisinone for Treatment of Alkaptonuria
Alkaptonuria affects approximately 1 in 250,000 to 1 million people in the United States.
Scripted for Her: Addressing Preconception Health Through MTM
In this episode, Natalie DiPietro Mager, PharmD, PhD speaks with David Bright, PharmD, MBA, professor at Ferris State University College of Pharmacy.
FDA Approves Lenacapavir for Prevention of HIV
The decision makes the therapy the first and only twice-yearly option available in the United States for PrEP.
Gut Microbiome Composition Could Be Linked With Risk of Cognitive Impairment
In the study, the composition of the gut microbiome could also be affected by food insecurity, a known social determinant of health.
